DARPins: A new generation of protein therapeutics
- 31 August 2008
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 13 (15-16), 695-701
- https://doi.org/10.1016/j.drudis.2008.04.013
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs"Protein Engineering, Design and Selection", 2008
- VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockadeProceedings of the National Academy of Sciences of the United States of America, 2007
- A Designed Ankyrin Repeat Protein Evolved to Picomolar Affinity to Her2Journal of Molecular Biology, 2007
- Supreme Court boosts licensees in biotech patent battlesNature Biotechnology, 2007
- Drug Export Pathway of Multidrug Exporter AcrB Revealed by DARPin InhibitorsPLoS Biology, 2006
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Somatic diversification of variable lymphocyte receptors in the agnathan sea lampreyNature, 2004
- Initial sequencing and analysis of the human genomeNature, 2001
- PegylationClinical Pharmacokinetics, 2001